Moreover, compelling evidence suggests that tumor cells exploit their metabolic advantage to deplete extracellular glutamine, creating a nutrient-deprived TME that compromises CD8+ T cell function and antitumor immunity (20–23). The gene discussed is CD8A; the disease is neoplasm.